bumetanide has been researched along with Premenstrual Syndrome in 2 studies
Premenstrual Syndrome: A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse (such as pain, water-retention, anxiety, cravings, and depression) and they diminish markedly 2 or 3 days after the initiation of menses.
Excerpt | Relevance | Reference |
---|---|---|
"Treatment with bumetanide or bromocriptine had no effect on the parameters studied." | 1.26 | Body water and weight in patients with premenstrual tension. ( Andersch, B; Andersson, M; Hahn, L; Isaksson, B, 1978) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andersch, B | 2 |
Hahn, L | 2 |
Wendestam, C | 1 |
Ohman, R | 1 |
Abrahamsson, L | 1 |
Andersson, M | 1 |
Isaksson, B | 1 |
1 trial available for bumetanide and Premenstrual Syndrome
Article | Year |
---|---|
Treatment of premenstrual tension syndrome with bromocriptine.
Topics: Adult; Bromocriptine; Bumetanide; Clinical Trials as Topic; Drug Evaluation; Estradiol; Female; Foll | 1978 |
1 other study available for bumetanide and Premenstrual Syndrome
Article | Year |
---|---|
Body water and weight in patients with premenstrual tension.
Topics: Adult; Body Water; Body Weight; Bromocriptine; Bumetanide; Female; Humans; Menstruation; Middle Aged | 1978 |